Endologix Profit Margin 2006-2018 | ELGX
Current and historical gross margin, operating margin and net profit margin for Endologix (ELGX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Endologix net profit margin as of December 31, 2018 is -50.94%.
|Endologix Annual Profit Margins
|Endologix Quarterly Profit Margins
||Medical & Dental Supplies
Endologix, Inc. develops, manufactures and markets products for the treatment of coronary and vascular diseases. A leader in the emerging field of vascular brachytherapy, Endologix, has developed a unique method for the delivery of radiation to prevent restenosis following the interventional treatment of atherosclerosis.